Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inter-relationships between vascular thromboxane and prostacyclin synthesis.

M J James1, J A Walsh

  • 1Department of Surgery, Flinders Medical Centre, Bedford Park, South Australia.

Prostaglandins, Leukotrienes, and Essential Fatty Acids
|February 1, 1988
PubMed
Summary

Arachidonic acid boosts thromboxane synthesis in artery slices but not prostacyclin. Dexamethasone treatment enables arachidonic acid to increase both, altering the prostacyclin/thromboxane ratio and potentially vascular endothelium thrombogenicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial.

Clinical rheumatology·2018
Same author

Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial.

Clinical rheumatology·2018
Same author

Hot Water as a Hæmostatic.

The Indian medical gazette·2017
Same author

Onset of psoriatic arthritis during ustekinumab treatment for psoriasis: a case series of seven patients.

The British journal of dermatology·2015
Same author

Blending research, service and cost-effectiveness in prevention: What helps and what hinders?

The journal of primary prevention·2013
Same author

U-shaped relationship between tissue docosahexaenoic acid and atrial fibrillation following cardiac surgery.

European journal of clinical nutrition·2013

Area of Science:

  • Biochemistry
  • Vascular Biology
  • Pharmacology

Background:

  • Prostacyclin and thromboxane are key regulators of vascular homeostasis.
  • Arachidonic acid is a precursor to both prostacyclin and thromboxane.
  • The balance between prostacyclin and thromboxane influences thrombogenicity.

Purpose of the Study:

  • To investigate the dose-dependent effects of arachidonic acid on prostacyclin and thromboxane synthesis in human umbilical artery.
  • To determine if dexamethasone influences the response of artery slices to arachidonic acid.
  • To elucidate the impact of arachidonic acid on the prostacyclin/thromboxane ratio and vascular endothelium thrombogenicity.

Main Methods:

  • Human umbilical artery slices were incubated with varying concentrations of arachidonic acid.

Related Experiment Videos

  • Prostacyclin and thromboxane synthesis rates were measured.
  • Experiments were conducted on both untreated and dexamethasone-treated artery slices.

    • Main Results:

    • Increasing arachidonic acid concentrations elevated thromboxane synthesis but did not affect prostacyclin synthesis in untreated slices.
    • In dexamethasone-treated slices, arachidonic acid increased the synthesis of both thromboxane and prostacyclin.
    • Arachidonic acid was shown to alter the prostacyclin/thromboxane synthesis ratio in untreated artery slices.

    Conclusions:

    • Arachidonic acid modulates the prostacyclin/thromboxane ratio, suggesting a potential mechanism for altering vascular endothelium thrombogenicity.
    • Dexamethasone influences the arachidonic acid-mediated synthesis of prostanoids in the vascular endothelium.
    • Further research is warranted to fully understand the proposed mechanism of arachidonate-induced changes in the prostacyclin/thromboxane ratio.